ILIUM XYLAZIL-100 ANALGESIC, SEDATIVE AND MUSCLE RELAXANT INJECTION

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

XYLAZINE AS THE HYDROCHLORIDE

Available from:

TROY LABORATORIES PTY LTD

INN (International Name):

xylazine as HCl(100mg/mL)

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

XYLAZINE AS THE HYDROCHLORIDE THIAZOLE Active 100.0 mg/ml

Units in package:

50mL

Class:

VM - Veterinary Medicine

Manufactured by:

TROY LABORATORIES

Therapeutic group:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Therapeutic area:

CENTRAL NERVOUS SYSTEM

Therapeutic indications:

ANALGESIC | MUSCLE RELAXANT | ANAESTHETIC | ANTIPYRETIC | COLIC | GENERAL ANAESTHETIC | MUSCLE RELAXANT | MUSCULAR SPASMS | PARASYMPATHOLYTIC AGENT | SEDATIVE | SPASMOLYTIC | STRYCHNINE POISONING

Product summary:

Poison schedule: 4; Withholding period: DO NOT USE less than 28 days before slau ghter for human consumption. Any variat ion by the prescribing veterinarian to t he approved use pattern, may require an extended withholding period. An ESI has not been established for this product. Note – observing the meat withholding p eriod may not be sufficient to mitigate potential risks to export trade. Trade advice should be sought from Troy Labora tories on (+61) 2 8808 3600 before usin g this product.; Host/pest details: DEER: [ANALGESIC, MUSCLE RELAXANT, SEDATIVE]; HORSE: [ANALGESIC, MUSCLE RELAXANT]; Poison schedule: 4; Withholding period: WHP: MEAT: 28 days.; Host/pest details: HORSE: [ANALGESIC, MUSCLE RELAXANT]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANALGESIC, MUSCLE RELAXANT]; Ilium Xylazil-100 is an analgesic, sedative and muscle relaxant injection for use in horses.

Authorization status:

Registered

Authorization date:

2022-07-01

Patient Information leaflet

                                _Main _
PANEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM XYLAZIL-100
ANALGESIC, SEDATIVE AND MUSCLE
RELAXANT INJECTION
ACTIVE CONSTITUENT:
100 mg/mL XYLAZINE AS HYDROCHLORIDE
ILIUM
50mL
_Ancillary_
_Dane/_
_ _
_1_
Ilium Xylazil-100 is an analgesic, sedative and muscle relaxant
injection for use
in horses.
DIRECTIONS FOR USE:
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
HORSES
- 0.5
-
1.1
mg/kg
b.w. (051.1
mL/lOO
kg b.w.) slow i.v.
1.0-2.2 mg/kg b.w. (1.0-2.2
mL/lOO
kg b.w.) i.m.
MEAT WITHHOLDING PERIOD: 28 DAYS
_
_Ancillary_
_panel 2_
TROY LABORATORIES PTY. LIMITED
98 LONG ST. SMITHFIELD, NSW 2164 AUSTRALIA
Dispose of empty container by wrapping with paper and putting in the
garbage.
Store below
30%
(Room Temperature).
NRA Approval No.
38654/ti..3-7%
Expiry:
_Draft CARTON _
_-_
_ 25 February 1998_
_y-d++_
_Main panel_
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM XYLAZIL-100
ANALGESIC, SEDATIVE AND MUSCLE
RELAXANT INJECTION
ACTIVE CONSTITUENT:
100 mg/mL XYLAZINE AS HYDROCHLORIDE
ILIUM
50mL
_Ancillary_
_panel_
Ilium Xylazil-100 is an analgesic, sedative and muscle relaxant
injection for use
in horses.
DIRECTIONS FOR USE:
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
HORSES
- 0.5
-
1.1 mg/kg b.w. (051.1
mL/lOO
kg b.w.) slow
i.v.
1.0-2.2
mg/kg b.w. (1.0-2.2
mL/lOO
kg b.w.) i.m.
MEAT WITHHOLDING PERIOD: 28 DAYS
TROY LABORATORIES PTY. LIMITED
98 LONG ST. SMITHFIELD, NSW 2164 AUSTRALIA
Dispose of empty container by wrapping with paper and putting in the
garbage.
Store below 30°C (Room Temperature).
NRA Approval No.
38654/C..+
7~
Batch:
Expiry:
_Draft LABEL _
_-_
_ 25 February 1998_
_w+-f+-_
_T_
_CM_
_ _
_h/d?_
_ _
_,A_
_ _
_C?.&_
_c~t~.dP-_
_One panel leaflet_
_._
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM XYLAZIL-10 ANALGESIC, SEDATlVE AND
RELAXANT INJECTION
ACTIVE CONSTITUENT.
100
mg/mL
XYLAZINE AS HYDROCHLORIDE
50mL
DESCRIPTION:
XYLAZIL-100 IS AN injection containing 
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ILIUM XYLAZIL-100 ANALGESIC, SEDATIVE AND MUSCLE
RELAXANT INJECTION
PAGE: 1 OF 4
THIS REVISION ISSUED: JULY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Troy Laboratories Australia Pty Ltd
Phone: 02 9677 9000
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
(02)9677 9000
31-35 GLENDENNING ROAD
FAX:
(02) 9677 9300
GLENDENNING NSW 2761
CHEMICAL NATURE:
Water solution of ingredients. Active ingredient is Xylazine is an
alpha-2 adrenergic,
non narcotic sedative.
TRADE NAME:
ILIUM XYLAZIL-100 ANALGESIC, SEDATIVE AND MUSCLE RELAXANT
INJECTION
PRODUCT CODE:
3828
PRODUCT USE:
A non-narcotic analgesic, sedative and muscle relaxant for use in
horses. To be used
as directed on product label.
CREATION DATE:
AUGUST, 2005
THIS VERSION ISSUED:
JULY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S25. Avoid contact with eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear, colourless liquid.
ODOUR:
Very faint odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
This is a pharmacologically active preparation, and contact should be
avoided except in actual use. If you have come
into contact with this product, seek medical attention if you feel
drowsy or experience any unusual symptoms.
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that
this product is not harm
                                
                                Read the complete document